News for Healthier Living

Switching From Dulaglutide to Tirzepatide Boosts Patient-Reported Well-Being for People with Type 2 Diabetes

An analysis of patient-reported outcomes (PROs) from the SURPASS-SWITCH trial found that adults with type 2 diabetes who switched from dulaglutide to tirzepatide not only saw stronger improvements in blood sugar and weight but also reported feeling emotionally better.

March 30, 2026


March 30 2026

March 29 2026

March 28 2026

March 27 2026

March 26 2026

March 25 2026

March 24 2026

March 23 2026

March 22 2026

March 21 2026

March 20 2026

March 19 2026

March 18 2026

March 17 2026